STAGE III NSCLC
Clinical trials for STAGE III NSCLC explained in plain language.
Never miss a new study
Get alerted when new STAGE III NSCLC trials appear
Sign up with your email to follow new studies for STAGE III NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to shrink lung tumors before surgery
Disease control Recruiting nowThis study tests a combination of chemotherapy and immunotherapy (tislelizumab) given before surgery for people with stage III non-small cell lung cancer that is PD-L1 positive. The goal is to see if this approach helps more patients have successful surgery to remove all cancer. …
Matched conditions: STAGE III NSCLC
Phase: PHASE2 • Sponsor: Fondazione Ricerca Traslazionale • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New combo therapy holds promise for Tough-to-Treat lung cancer patients
Disease control Recruiting nowThis study is for elderly or less healthy patients with stage III lung cancer that cannot be removed by surgery. It tests whether adding immunotherapy to chemotherapy before radiation therapy can help control the cancer longer. About 152 participants will be randomly assigned to …
Matched conditions: STAGE III NSCLC
Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated May 14, 2026 12:03 UTC